Venture Capital

Medtech firm IMPLANET reports a landmark €12.5M revenue year, fueled by strong international sales, US growth, and a strategic pivot into robotics.

Moving beyond hype, ArisGlobal's record growth and enterprise adoption of its NavaX AI show the pharmaceutical industry is now operationalizing AI at scale.

With a new finance head, the non-profit plans to launch a breakthrough vitamin A product in Africa, blending philanthropy with commercial strategy.

With a sold-out show, Work Truck Week 2026 is a launchpad for new EVs, hydrogen tech, and smart systems, signaling a robust future for commercial vehicles.

Rivian's RJ Scaringe and Mack's Stephen Roy will keynote ACT Expo 2026, signaling a new era where fleet electrification meets AI-driven intelligence.

Genomics giant Illumina launches a vast biological dataset with pharma partners, aiming to train AI and revolutionize how we find new medicines.

The U.S. Army partners with Velo3D, using advanced 3D printing to create mission-critical metal parts and bolster the readiness of its combat fleet.

With three new executive appointments, Armada signals an aggressive new strategy under CEO Chris O'Brien to unify its brand and accelerate growth.

A new alliance aims to solve a critical scaling bottleneck in photonic quantum computing, accelerating the race to build a useful, large-scale machine.

O Positiv's new menopause and metabolism products at Target signal a market shift. But how strong is the science behind these 'clinically studied' formulas?

Goldflower Cannabis expands to Fort Pierce, launching 'The Freedom Roll' to aid cannabis prisoners and veterans, blending rapid growth with social equity.

Propanc Biopharma is taking a 100-year-old cancer treatment concept into modern human trials, targeting advanced tumors and expanding into fibrosis.

Unveiled at CES 2026, this award-winning expandable home on wheels promises AI-powered, self-sufficient living for a new generation of nomads.

A novel vaccine protects shrimp by immunizing their parents, offering a solution to devastating outbreaks and a path to sustainable global protein production.

A new study shows the professional services market is slowing, but elite firms are widening the gap with a bold playbook of high investment and AI mastery.

A new partnership seeks to harness fault-tolerant quantum computers, promising to solve aerospace's most complex fluid dynamics problems.

Vericel posts strong 2025 results driven by its MACI cartilage therapy. The biotech leader is now investing in a new facility and a clinical trial for ankle repair.

With a former mayor and Airbnb policy chief now in its C-suite, EverDriven signals a push to rewrite the rules for getting vulnerable students to school.

A new partnership embeds Nasdaq's institutional data into Juniper Square's AI CRM, promising to end manual work for investor relations teams.

RAAPID’s award-winning Neuro-Symbolic AI brings transparency to risk adjustment, promising audit-ready accuracy and major ROI for value-based care.